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Background: Depressive symptoms in patients with type 2 diabetes mellitus (T2DM) have attracted much attention
in recent years, and negatively affect the health of diabetic patients in numerous ways. This study evaluated the
prevalence rate of depressive symptoms in T2DM patients in Shanghai, and the potential factors that may be
associated with depressive symptoms in this select population.
Methods: A total of 865 T2DM patients were recruited from Longhua Street, Xuhui, Shanghai by simple random
sampling, and all the patients were assessed with the Zung Self-rating Depression Scale to screen for depressive
symptoms. Factors associated with depressive symptoms were analyzed by logistic regression.
Results: Among the 865 patients (403 were male, 462 were female, average age 70.13 ± 20.33 years), 304 (35.1%)
patients were categorized as having depressive symptoms. Rates of myocardial infarction and stress in one month
were higher in the depressive symptoms group than in the non-depressive symptoms group by the X2 test. Rates
of patients having a job, having a college education or above, and sleeping less than 7 h/24 h day were also higher
in the depressive symptoms group by the X2 test. Body mass index, and levels of total cholesterol, triglyceride,
urea, creatinine, uric acid, and homocysteine were higher in the depressive symptoms group by the independent
samples t test and non-parametric test. Sleeping hours, history of myocardial infarction, stress in one month,
working status, and total cholesterol were significantly associated with depressive symptoms (p < 0.05).
Conclusions: In the Chinese population analyzed in this study, the prevalence rate of depressive symptoms in
patients with T2DM was high. Further research on the relationship between diabetes and depressive symptoms is
necessary in a wider Chinese population.
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Type 2 diabetes mellitus (T2DM) is one of the most com-
mon chronic diseases worldwide, and its prevalence rate
has been rising each year. It is anticipated that the global
prevalence of T2DM will increase to 438 million by the
year 2030 [1]. People with diabetes have a mortality rate
that is twice as high as people of a similar age without dia-
betes. In recent years, it was found that people with dia-
betes are at an increased risk of experiencing depressive
conditions in their lifetime. For example, individuals with* Correspondence: lingfenglh04@163.com
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unless otherwise stated.diabetes mellitus have been shown to have twice the risk
of depression as those without diabetes [2], a finding that
has been supported by other studies [3]. Importantly, dia-
betic patients with depression were shown to have a sig-
nificantly higher rate of negative outcomes such as
diabetic complications [4], cardiovascular disease, and all-
cause mortality risk [5] than those without depression,
and individuals with depression were less likely to adhere
to their medications than those without depression [6,7].
In addition, in comparisons of patients with T2DM and
depression with those without depression, the risk of de-
mentia was significantly increased in patients having by
both T2DM and depression [8]. Numerous studies have
reported that the coexistence of diabetes and depressionThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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was also noted that effective treatment for depression may
greatly attenuate the strong link between depression and
mortality in an older population with T2DM [11]. Sadly,
this depression often remains unrecognized and untreated
[12], thus increasing the prevalence of depression among
people with T2DM [12,13]. Therefore, it is critical to diag-
nose depression in diabetic patients as early as possible
and provide them with the corresponding treatments.
In Beijing, a city in northern China and the capital of
the country, it was found that the prevalence rate of de-
pressive symptoms in T2DM patients was 44.23% [14].
However, studies on the prevalence of depressive symp-
toms in patients with T2DM in Shanghai (a city in east-
ern China and the biggest city in country) were rare. In
view of the high prevalence and the marked differences
reported within China, it would also be important to
learn about the prevalence of depressive symptoms in
T2DM patients in Shanghai.
The purpose of this study was to identify the preva-
lence rate of depressive symptoms in T2DM patients
and the risk factors related to depressive symptoms in
Shanghai. These consequences need to be urgently con-
sidered to find efficient intervention methods to reduce
the occurrence of complications and deaths of patients
with both T2DM and depressive symptoms.
Methods
Research sample
The patients surveyed in this cross-sectional study were
selected randomly from all the T2DM patients in Longhua
Street, Xuhui, Shanghai. The calculation of the sample size
was based on the finding that the prevalence rate of de-
pressive symptoms in T2DM patients was 35.6% in the
center region of China; the level of α = 0.05, the allowable
error = 10%, and invalid questionnaire rate = 10%. Based
on these facts it was calculated that a total of 796 cases
were needed for the present study. We were able to collect
a total of 910 cases. Questionnaires with responses that
did not meet the inclusion criteria and lacked sufficient
data were excluded. Finally, 865 participants were included
in this study. Subjects who met the following inclusion
criteria were eligible for participation: (1) diagnosed as
T2DM according to World Health Organization criteria
in 1999; (2) without mental disease and related family his-
tory; (3) no history of drugs that influenced mental health;
and (4) individuals who volunteered to participate in this
study. Individuals who experienced acute complications of
diabetes, those who indicated that they had serious heart,
lung, kidney, or other organ dysfunctions, or had severe
infection were excluded from the study.
The research protocol was approved by the Ethics Com-
mittee of Longhua Street Community Health Center.
Researchers explained the purpose of the study andprocedures to the participants before their interviews. All
the participants were informed that their participation was
voluntary, and each of the participants signed an informed
consent form.
Measurements and assessments of depressive status
Demographic and clinical characteristics of the patients,
such as age, sex, body mass index (BMI), work status, fast-
ing blood glucose, triglycerides (TG), total cholesterol
(TC), pre-existing medical conditions, and history of stress
in one month, were collected in this study. Among them,
“history of stress in one month” meant that the patients
experienced stressful events such as changes in their work
status or lost their jobs, or their lineal relatives got sick or
died within a one month timeframe.
The Chinese version of the Zung Self-rating Depression
Scale (ZSDS) was used to screen depressive symptoms.
ZSDS was identified as a useful and well-validated ques-
tionnaire by Chinese psychiatrists [15]. ZSDS contains 20
items. Every item can be scored from 1 (where depressive
symptoms are very seldom) to 4 (where depressive symp-
toms are most of the time). The total score was defined as
the sum of the total numbers obtained in the 20 items,
and the standardized score is equal to 1.25 times the total
score. Subjects were classified according to their standard-
ized scores. According to the Chinese norm of ZSDS, de-
pressive symptoms were defined as a standardized score of
53 or higher; 53–62 indicates mild depressive symptoms,
63–72 indicates moderate depressive symptoms, and >72
indicates severe depressive symptoms [16]. In this study,
the patients were divided into two groups for analysis: pa-
tients with their standardized scores ≥53 were classified as
the “depressive symptoms” group, and patients with their
standardized <53 were classified as the “non-depressive
symptoms” group.
Statistical analyses
Statistical analyses were performed with SPSS 19.0. Con-
tinuous variables were expressed as mean ± standard devi-
ation. Discrete variables were expressed as absolute values
and percentages. The comparison of continuous variables
used the independent sample t-test or non-parametric
test. Pearson’s chi-square test or Fisher’s exact test was
used for the comparison of rates of discrete variables. Lo-
gistic regression analysis was used to evaluate the variables
correlated with depressive symptoms in diabetic patients.
p < 0.05 was considered as statistically significant.
Results
Demographic characteristics and disease-related parameters
of diabetic patients in the depressive symptoms group and
the non-depressive symptoms group
A total of 865 patients were included in the present
study, and the response rate was 95.1%. Among them,
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The mean (± standard deviation) age of the participants
was 70.13 (±20.33) years. In this study, the prevalence
rate of depressive symptoms was 35.1%, and the rates of
mild, moderate, and severe depressive symptoms were
28.2%, 6.7%, and 0.2%, respectively.
The participants’ main demographic characteristics are
shown in Table 1. The rates of patients with a job and
patients with a college education or above were higher
in the depressive symptoms group than in the non-
depressive symptoms group, and the average salary was
higher in the depressive symptoms group.
The participants’ disease-related parameters are pre-
sented in Table 2. Diabetic patients with depressive symp-
toms had higher rates of myocardial infarction and stress in
one month, and the rate of participants sleeping more than
7 h/24 h day was lower in the depressive symptoms group.
BMI and the levels of TC, TG, urea, creatinine, uric acid,
and homocysteine were higher in the depressive symptoms
group than in the non-depressive symptoms group.
Factors associated with depressive symptoms among
participants with diabetes by logistic regression
Table 3 shows factors associated with depressive symp-
toms among participants with diabetes. Participants
who slept less than 7 h/24 h day had an average of 2.52
(95% confidence interval [CI] 1.59–3.98) higher depres-
sive symptoms incidence compared with those who
slept more than 7 h/24 h day (p < 0.001). Participants
with myocardial infarction had an average of 3.91 (95%
CI 1.16–13.22) higher depressive symptoms incidence
compared with those without myocardial infarction
(p = 0.028). Participants who had a job had an average
of 1.68 (95% CI 1.13–2.48) higher depressive symptoms
incidence compared with those who did not have a job
(p = 0.010). Participants who had a history of stress in
one month had an average of 4.49 (95% CI 1.08–18.62)
higher depressive symptoms incidence compared with
those without stress (p = 0.039). When TC raised
1 mmol/L, participants had an average of 1.29 (95% CI




Age (years) 69.25 ± 18.51
Marriage status (married, n/%) 495/88.7
Working status (on job, n/%) 216/38.5
Educational background (college and above, n/%) 98/17.5
Average salary (RMB) 4022.47 ± 1726.62Discussion
This study shows for the first time the prevalence of de-
pressive symptoms in a large group of patients with
T2DM in Shanghai. Importantly, the study was con-
ducted at the community level and the selection bias
was reduced.
In this community-based sample of adult patients with
T2DM, it was found that the prevalence rate of depres-
sive symptoms in the participants was 35.1%. This rate
was different from and lower than the rate in Beijing
[14]. This may be because of the possibility that people
in different areas of China have different living habits,
and thus more research in this field may be needed with
the inclusion of more cities in China. Although the rate
of depressive symptoms in Shanghai was not as high as
rates of other cities in China, none of the patients was
aware of his/her depressive symptoms, and therefore
his/her depression did not get timely treatment. Evi-
dence shows that efficacious pharmacological and psy-
chosocial treatments are available to patients with
depressive symptoms [17,18], but if a patient declined
medication therapy, the physician could recommend
interpersonal psychotherapy from a healthcare manager.
If diabetic patients with depressive symptoms were
treated in a timely manner, it may reduce the occurrence
of complications and even death.
The second goal of this study was to find the differ-
ences between T2DM patients with and without depres-
sive symptoms. Significant differences were found in the
rates of myocardial infarction and stress, work status,
sleeping hours, educational background, average salary,
and in BMI and in levels of TC, TG, urea, creatinine,
uric acid, and homocysteine. Notably, educational level
and average salary were higher in the depressive symp-
toms group than in the non-depressive symptoms group.
It may be possible that the patients in the depressive
symptoms group had more pressures at their work.
Among the factors mentioned above, it was found that
amount of sleeping hours, history of myocardial infarc-
tion and stress in one month, working status, and TC
were significantly associated with the occurrence ofms group Depressive symptoms group Overall subjects P-value
(ZSDS score ≥ 53)
140/46.1 403/46.6 0.816




4878.87 ± 1909.81 4254.18 ± 1817.02 0.000
Table 2 Disease-related parameters of T2DM patients with and without depressive symptoms
Characteristic Non-depressive symptoms group Depressive symptoms group Overall subjects P-value
(ZSDS score <53) (ZSDS score ≥ 53)
History(n/%)
Hypertension 424/75.6 240/79.2 664/76.9 0.23
Valvular heart disease 7/1.3 5/1.7 12/1.4 0.63
Dyslipidaemia 197/35.2 104/34.3 301/34.9 0.801
Myocardial infarction 7/1.2 11/3.6 18/2.1 0.020
Stress in one month 4/0.7 9/3.0 13/1.5 0.01
Sleeping hours(>7 h / 24 h day, n/%) 148/26.6 42/16.3 190/23.3 0.001
BMI (kg/m2) 24.10 ± 3.11 24.54 ± 3.23 24.25 ± 3.16 0.047
SBP (mmHg) 127.84 ± 9.68 127.34 ± 9.95 127.66 ± 9.77 0.47
DBP (mmHg) 77.61 ± 6.10 77.40 ± 6.44 77.53 ± 6.22 0.64
FBG (mmol/L) 7.05 ± 1.73 6.94 ± 1.56 7.01 ± 1.67 0.39
HbA1C (%) 6.69 ± 1.31 6.62 ± 0.93 6.67 ± 1.19 0.40
TC (mmol/L) 5.23 ± 1.09 5.82 ± 2.51 5.23 ± 1.09 0.00
TG (mmol/L) 1.96 ± 1.13 2.13 ± 1.10 2.02 ± 1.12 0.036
Urea (mmol/L) 6.71 ± 4.00 15.08 ± 22.11 10.06 ± 14.88 0.00
Creatinine (μmol/L) 72.40 ± 25.12 80.15 ± 24.92 75.58 ± 25.31 0.00
Uric acid (μmol/L) 294.49 ± 89.86 308.55 ± 77.81 300.25 ± 85.35 0.038
Homocysteine (μmol/L) 8.53 ± 4.47 10.93 ± 9.44 9.49 ± 6.98 0.00
Diabetes duration (years) 8.69 ± 6.89 9.58 ± 7.32 9.00 ± 7.05 0.077
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gression. Thus, in future studies, researchers should pay
more attention to patients who comply with the factors
mentioned above, and intervene on behalf of diabetic pa-
tients with regard to those factors that play a significant
role in the prevention of depressive symptoms.
This study was conducted at the community level and
without the influence of the hospital environment on dia-
betic patients, thus selection bias was reduced. Further-
more, this study shows for the first time the prevalence of
depressive symptoms of T2DM patients in the biggest city
in China. In addition, we also found statistically significant
factors associated with depressive symptoms.
Although this study produced important results, there
were some limitations. First, the diagnosis of depressive
symptoms was by ZSDS only. It would have been more
reliable if the study diagnosed depressive symptomsTable 3 Risk factors associated with depressive symptoms in
Characteristic
Sleeping hours (reference > =7 h/24 h day)
History of myocardial infarction(reference no MI)
Working status (reference not on job)
History of stress in one month (reference no stress)
TC (mmol/L)combined with other scales. Specifically, the average age
of the participants in the study was 70.13 years and for
people of this age, diagnosis depressive symptoms com-
bined with the Geriatric Depression Scale may be more
appropriate. Second, the patients in this study were from
one community only, which may not reflect the total
disease status of Shanghai. Third, it was not possible to
control for other potentially significant unmeasured
factors such as family history of other diseases, or other
environmental factors, or therapeutic adherence. Com-
bined with the findings of previous studies that both
micro- and macro-vascular diabetic complications are
enhanced by the presence of depression [19] in T2DM
patients, and that depression may speed the death of
diabetic patients [20,21], future studies will be necessary
to investigate more patients from different communities,
and more factors will need to be measured that may bediabetic patients by logistic regression analysis
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entirety of China. Bogner et al [22] also found that if
older individuals with depression and diabetes were
treated in a timely manner, they were less likely to die
within a 5-year interval. Thus, therapeutic intervention
of diabetic patients with depressive symptoms is needed
as early as possible.
Conclusions
This study found that about 35.1% of patients with
T2DM in Shanghai experience depressive symptoms. It
also revealed that sleeping hours, history of myocardial
infarction and stress in one month, working status, and
TC were significantly associated with the occurrence of
depressive symptoms. Because it has been shown that
depression is under-recognized and undertreated [21],
and depressive symptoms may negatively influence the
long-term outcome of diabetic patients [23], it would be
crucial to screen depressive symptoms in diabetic pa-
tients and intervene with effective treatment methods as
early as possible.
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